Home Cart 0 Sign in  
X

[ CAS No. 4892-02-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 4892-02-8
Chemical Structure| 4892-02-8
Chemical Structure| 4892-02-8
Structure of 4892-02-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4892-02-8 ]

Related Doc. of [ 4892-02-8 ]

Alternatived Products of [ 4892-02-8 ]

Product Details of [ 4892-02-8 ]

CAS No. :4892-02-8 MDL No. :MFCD00060678
Formula : C8H8O2S Boiling Point : -
Linear Structure Formula :- InChI Key :BAQGCWNPCFABAY-UHFFFAOYSA-N
M.W : 168.21 Pubchem ID :21009
Synonyms :

Calculated chemistry of [ 4892-02-8 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 44.97
TPSA : 65.1 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.79 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.08
Log Po/w (XLOGP3) : 2.16
Log Po/w (WLOGP) : 1.76
Log Po/w (MLOGP) : 2.2
Log Po/w (SILICOS-IT) : 1.97
Consensus Log Po/w : 2.03

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.52
Solubility : 0.513 mg/ml ; 0.00305 mol/l
Class : Soluble
Log S (Ali) : -3.16
Solubility : 0.116 mg/ml ; 0.000692 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.58
Solubility : 0.446 mg/ml ; 0.00265 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.32

Safety of [ 4892-02-8 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P501-P261-P270-P271-P264-P280-P337+P313-P305+P351+P338-P361+P364-P332+P313-P301+P310+P330-P302+P352+P312-P304+P340+P311-P403+P233-P405 UN#:2810
Hazard Statements:H301+H311+H331-H315-H319 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 4892-02-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4892-02-8 ]
  • Downstream synthetic route of [ 4892-02-8 ]

[ 4892-02-8 ] Synthesis Path-Upstream   1~21

  • 1
  • [ 4892-02-8 ]
  • [ 5556-20-7 ]
YieldReaction ConditionsOperation in experiment
88% With potassium <i>tert</i>-butylate In tetrahydrofuran at 20℃; for 0.283333 h; Inert atmosphere Intermediate 6: Ethyl-3-hydroxybenzo[6]thiophene-2-carboxylate To a solution of methyl-2-mercaptobenzoate (1.63 mL, 1 1.9 mmol) and ethyl bromoacetate (1.32 mL, 1 1.9 mmol) in dry tetrahydrofuran (130 mL) at 0 °C was added potassium fert-butoxide (5.14 g, 71.3 mmol) gradually over 2 min. The reaction mixture was stirred and allowed to warm to room temperature over 15 min, quenched with 2 M hydrochloric acid to pH 2 and diluted with 75 mL water. The product was immediately extracted with 3 χ 75 mL portions of ethyl acetate. The organic layers were combined, washed with 75 mL brine, dried over magnesium sulfate and concentrated under reduced pressure to give desired product as a yellow solid (2.32 g, 88percent). 3) 10.21 (IH, s), 7.94 (IH), 7.74 (IH), 7.50 (IH), 7.41 (IH), 4.43 (2H), 1.43 (3H).
Reference: [1] Patent: WO2013/83991, 2013, A1, . Location in patent: Page/Page column 68
  • 2
  • [ 105-36-2 ]
  • [ 4892-02-8 ]
  • [ 5556-20-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2017, vol. 60, # 5, p. 1959 - 1970
[2] Journal of Medicinal Chemistry, 2013, vol. 56, # 1, p. 371 - 375
  • 3
  • [ 67-56-1 ]
  • [ 147-93-3 ]
  • [ 4892-02-8 ]
YieldReaction ConditionsOperation in experiment
96% With sulfuric acid In water at 5℃; Reflux Example 1: Preparation of methyl 2-[6-(1-bromo-ethyl)-5-fluoropyrimidin-4-yl-sulfanyl]benzoate (Preparation of compound of formula 2 with substitution of -CO2CH3 at the ortho position); Step 1) Preparation of methyl 2-mercaptobenzoate
A mixed solution of 40g of 2-mercaptobenzoic acid and 600mL of methanol was cooled to 5.box. and 42mL of sulfuric acid was added dropwise thereto over 10 minutes.
After being refluxed for 14 hours, the reaction liquid was concentrated under reduced pressure.
The concentrate was diluted with 400mL of methylene chloride and 400mL of purified water and then the organic layer was separated.
The organic layer was successively washed with 200mL of a saturated sodium bicarbonate solution and 400mL of brine and then dried over anhydrous sodium sulfate.
After the organic layer was concentrated, the resulting residue was subjected to fractional distillation (118.box./7mmHg) to afford 42g (yield: 96percent) of the title compound as a clear oil.
1H-NMR (200MHz, CDCl3) δ (ppm): 8.01 (d,1H), 7.30 (d,2H), 7.14 (m,1H), 4.68 (s,SH), 3.91 (S,3H)
95% Reflux General procedure: To a solution of thiosalicilic acid 1 (15.4 g, 100 mmol) in methanol (600 mL) neat 98percent H2SO4 (10 mL) was added and the reaction mixture was heated at reflux for 72 h (TLC inn-hexanes/AcOEt 7:3), poured into cold H2O (500 mL) and the organics were extracted from acidic (by diluted HCl) water (pH<3) in CHCl3 (3 x 500 mL), dried over anhydrous Na2SO4, filtered and evaporated to dryness in vacuo. After flash chromatographic purification of the crude (n-hexane/ethyl acetate 7:3), methyl 2-mercaptobenzoate (3) was isolated as a colorless solid (15.9 g, 95percent). ESI-MS (m/z): 167 [M-H]+;. 1H and 13C NMR data were similar to those of the alreadydescribed compound. To a solution of 3 (15.9 g, 95.0 mmol) in CCl4(100 mL) at 0 °C, neat Br2 (7.82 g, 50.0 mmol) in CCl4 (250 mL) was added dropwise in 30 min. The reaction mixture was stirred at rt for additional 30 min while a colorless precipitate formed and was filtered to give the title compound 4 (28.5 g, 90percent).
94% for 48 h; Reflux Step 3: Methyl 2-mercaptobenzoate (18c)To a solution of 2-mercaptobenzoic acid (34 g, 220 mmol) in dry MeOH (150 mL) was added cone. H2S04 (4 mL) and the reaction was refluxed for 48 h. The solution was concentrated under reduced pressure and the residue was diluted with DCM and then sat. NaHC03 solution. The organic phase was washed with brine, dried over Na2S04 and concentrated under reduced pressure to give compound 18c (35 g, 94percent) as a yellow oil.
89.6% With sulfuric acid In water for 48 h; Heating / reflux Acid 1 (170.0 g, 1.1 mol), H2SO4 (20 mL, 0.37 mol) and anhydrous MeOH (300 mL) were refluxed for 2 days. The solvent was evaporated under reduced pressure. Water was added and the mixture was extracted with CH2Cl2 (3.x.1000 mL). The organic layers were combined, washed with aq. NaHCO3 (2.x.300 mL), water (2.x.250 mL), brine (500 mL) and dried over Na2SO4 to afford crude compound 2 (165.0 g, 89.6percent). This was used without further purification.
64% for 72 h; Heating / reflux o-Mercaptobenzoic acid (9.9 g, 64.2 mmol) was dissolved in methanol (300 ml) and concentrated sulfuric acid (0.5 ml) added. The reaction mixture was refluxed for 72 h. Chloroform (300 ml) was added and the resultant mixture extracted with water (two-100 ml aliquots) and 1percent sodium hydroxide (two-100 ml aliquots). The combined aqueous layers were added to chloroform (75 ml), ice (100 ml) and concentrated hydrochloric acid (8 ml). Chloroform (150 ml) was added, the layers separated, the organic layer dried (MgSO4) and filtered. The solvent was evaporated and the residue rectified at reduced pressure affording clean o-mercapto methyl benzoate (6.9 g, 41.0 mmol, 64percent), b.p. 103-108° C./2.7 Torr. l.r. (liquid film) 1710 cm-1. 1H n.m.r. (270 MHz) δ7.99, d, 1H; 7.29, d, 1H; 7.14, m, 2H; 4.68, s, 1H; 3.90, s, 3H. 13C n.m.r. δ167.09, 138.27, 132.45, 131.65, 130.86, 125.74, 124.62, 52.19. m/z 168 (21percent, M+), 136 (100percent), 108 (35percent).

Reference: [1] Patent: EP2444398, 2012, A2, . Location in patent: Page/Page column 9
[2] Tetrahedron, 2017, vol. 73, # 13, p. 1745 - 1761
[3] Patent: WO2013/64231, 2013, A1, . Location in patent: Page/Page column 62
[4] Journal of Medicinal Chemistry, 2018,
[5] Patent: US2007/167497, 2007, A1, . Location in patent: Page/Page column 28
[6] Chemical Biology and Drug Design, 2015, vol. 85, # 2, p. 145 - 152
[7] Chemische Berichte, 1987, vol. 120, p. 1151 - 1174
[8] Journal of Medicinal Chemistry, 1993, vol. 36, # 10, p. 1387 - 1392
[9] European Journal of Medicinal Chemistry, 1999, vol. 34, # 11, p. 895 - 901
[10] Australian Journal of Chemistry, 2000, vol. 53, # 1, p. 1 - 5
[11] Patent: US2003/220524, 2003, A1, . Location in patent: Page/Page column 25
[12] Tetrahedron Asymmetry, 2010, vol. 21, # 2, p. 241 - 246
[13] Chemische Berichte, 1899, vol. 32, p. 1156
[14] Justus Liebigs Annalen der Chemie, 1907, vol. 351, p. 413
[15] Canadian Journal of Chemistry, 1965, vol. 43, p. 3221 - 3231
[16] Journal of Heterocyclic Chemistry, 1991, vol. 28, # 2, p. 269 - 272
[17] Journal of the American Chemical Society, 1980, vol. 102, p. 2519
[18] Biological and Pharmaceutical Bulletin, 2000, vol. 23, # 2, p. 254 - 256
[19] Synthetic Communications, 2006, vol. 36, # 10, p. 1419 - 1429
[20] Australian Journal of Chemistry, 2008, vol. 61, # 7, p. 484 - 499
[21] Journal of Organic Chemistry, 2008, vol. 73, # 20, p. 8057 - 8068
[22] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 23, p. 7193 - 7196
[23] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 15, p. 5031 - 5034
[24] Medicinal Chemistry Research, 2013, vol. 22, # 3, p. 1305 - 1312
[25] Patent: US2013/90328, 2013, A1, . Location in patent: Paragraph 0102; 0103
[26] Patent: WO2013/53658, 2013, A1, . Location in patent: Page/Page column 15
  • 4
  • [ 7283-41-2 ]
  • [ 4892-02-8 ]
YieldReaction ConditionsOperation in experiment
85% With oxalyl dichloride In methanol for 6 h; Reflux To a methanol solution (50mL) of 6 (5.00g, 32.5mmol), SOCl2 was added slowly and the mixture was stirred at 0°C for 1h. The obtained mixture was then heated to reflux for 6h. The solvent was removed under reduced pressure. The residue was dissolved in ethyl acetate (50mL), and washed with saturated NaHCO3 (50mL×2) and brine, dried with anhydrous Na2SO4. The crude product was purified by silica gel chromatography (petroleum ether–ethyl acetate=40:1 v/v as the eluent) to afford compound 7 as a colorless liquid (4.62g, 85percent).
Reference: [1] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 1, p. 374 - 380
[2] Patent: US5104882, 1992, A,
  • 5
  • [ 152766-18-2 ]
  • [ 4892-02-8 ]
Reference: [1] Synlett, 2001, # 12, p. 1956 - 1958
  • 6
  • [ 77586-85-7 ]
  • [ 4892-02-8 ]
Reference: [1] Helvetica Chimica Acta, 2006, vol. 89, # 5, p. 991 - 999
  • 7
  • [ 5459-63-2 ]
  • [ 4892-02-8 ]
Reference: [1] Journal of Organic Chemistry, 1984, vol. 49, # 14, p. 2637 - 2639
[2] Arkivoc, 2012, vol. 2012, # 6, p. 245 - 252
[3] Synthesis, 1974, p. 59 - 60
[4] Journal of the American Chemical Society, 1974, vol. 96, # 19, p. 6081 - 6089
  • 8
  • [ 119-80-2 ]
  • [ 4892-02-8 ]
Reference: [1] Journal of the American Chemical Society, 1974, vol. 96, # 19, p. 6081 - 6089
  • 9
  • [ 67-56-1 ]
  • [ 7283-41-2 ]
  • [ 4892-02-8 ]
Reference: [1] Archiv der Pharmazie, 2014, vol. 347, # 5, p. 327 - 333
  • 10
  • [ 67-56-1 ]
  • [ 21083-36-3 ]
  • [ 21083-38-5 ]
  • [ 5459-63-2 ]
  • [ 39264-06-7 ]
  • [ 4892-02-8 ]
Reference: [1] Journal of Organic Chemistry, 1987, vol. 52, # 17, p. 3838 - 3847
[2] Journal of Organic Chemistry, 1987, vol. 52, # 17, p. 3838 - 3847
  • 11
  • [ 13511-92-7 ]
  • [ 4892-02-8 ]
Reference: [1] Synthetic Communications, 1996, vol. 26, # 13, p. 2461 - 2471
  • 12
  • [ 5651-33-2 ]
  • [ 4892-02-8 ]
Reference: [1] Helvetica Chimica Acta, 2006, vol. 89, # 5, p. 991 - 999
  • 13
  • [ 67-56-1 ]
  • [ 1677-27-6 ]
  • [ 4892-02-8 ]
Reference: [1] Tetrahedron Letters, 1995, vol. 36, # 9, p. 1391 - 1394
[2] Tetrahedron Letters, 1995, vol. 36, # 9, p. 1391 - 1394
  • 14
  • [ 134-20-3 ]
  • [ 4892-02-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 1997, vol. 7, # 13, p. 1709 - 1714
  • 15
  • [ 13165-80-5 ]
  • [ 4892-02-8 ]
Reference: [1] Chemische Berichte, 1899, vol. 32, p. 1156
  • 16
  • [ 67-56-1 ]
  • [ 16671-86-6 ]
  • [ 4892-02-8 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1907, vol. 351, p. 413
  • 17
  • [ 51471-72-8 ]
  • [ 298-12-4 ]
  • [ 4892-02-8 ]
Reference: [1] International Journal of Chemical Kinetics, 1995, vol. 27, # 5, p. 443 - 452
  • 18
  • [ 7647-01-0 ]
  • [ 67-56-1 ]
  • [ 16671-86-6 ]
  • [ 4892-02-8 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1907, vol. 351, p. 413
  • 19
  • [ 127-65-1 ]
  • [ 4892-02-8 ]
  • [ 26638-43-7 ]
Reference: [1] Journal of Organic Chemistry, 2016, vol. 81, # 7, p. 3051 - 3057
  • 20
  • [ 4892-02-8 ]
  • [ 440627-14-5 ]
Reference: [1] Organic Letters, 2006, vol. 8, # 9, p. 1771 - 1773
[2] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 13, p. 3956 - 3964
[3] Journal of Medicinal Chemistry, 2014, vol. 57, # 8, p. 3450 - 3463
[4] Patent: WO2015/17412, 2015, A1,
[5] Patent: WO2015/138895, 2015, A1,
[6] Patent: WO2017/48954, 2017, A1,
[7] Patent: WO2018/53157, 2018, A1,
  • 21
  • [ 4892-02-8 ]
  • [ 431980-38-0 ]
Reference: [1] ChemMedChem, 2012, vol. 7, # 7, p. 1217 - 1229
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4892-02-8 ]

Aryls

Chemical Structure| 119-80-2

[ 119-80-2 ]

2,2'-Dithiodibenzoic acid

Similarity: 0.79

Chemical Structure| 61954-80-1

[ 61954-80-1 ]

5-Bromo-2-mercaptobenzoic acid

Similarity: 0.76

Chemical Structure| 29886-63-3

[ 29886-63-3 ]

3-(Thiophen-2-yl)benzoic acid

Similarity: 0.73

Chemical Structure| 825-99-0

[ 825-99-0 ]

3-(Methylthio)benzoic acid

Similarity: 0.73

Chemical Structure| 38588-64-6

[ 38588-64-6 ]

3,5-Bis(methoxycarbonyl)benzoic acid

Similarity: 0.70

Esters

Chemical Structure| 38588-64-6

[ 38588-64-6 ]

3,5-Bis(methoxycarbonyl)benzoic acid

Similarity: 0.70

Chemical Structure| 167300-06-3

[ 167300-06-3 ]

3-(Methoxycarbonyl)-4-methylbenzoic acid

Similarity: 0.70

Chemical Structure| 52178-50-4

[ 52178-50-4 ]

Methyl 3-formylbenzoate

Similarity: 0.70

Chemical Structure| 99-75-2

[ 99-75-2 ]

Methyl 4-methylbenzoate

Similarity: 0.70

Chemical Structure| 25081-39-4

[ 25081-39-4 ]

Methyl 3,5-dimethylbenzoate

Similarity: 0.70

Related Parent Nucleus of
[ 4892-02-8 ]

Thiophenols

Chemical Structure| 61954-80-1

[ 61954-80-1 ]

5-Bromo-2-mercaptobenzoic acid

Similarity: 0.76